159 related articles for article (PubMed ID: 12858342)
1. Vitamin D3 supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter.
Kitazawa S; Kajimoto K; Kondo T; Kitazawa R
J Cell Biochem; 2003 Jul; 89(4):771-7. PubMed ID: 12858342
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D(3) augments osteoclastogenesis via vitamin D-responsive element of mouse RANKL gene promoter.
Kitazawa R; Kitazawa S
Biochem Biophys Res Commun; 2002 Jan; 290(2):650-5. PubMed ID: 11785948
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic control of mouse receptor activator of NF-kappa B ligand gene expression.
Kitazawa S; Kitazawa R
Biochem Biophys Res Commun; 2002 Apr; 293(1):126-31. PubMed ID: 12054573
[TBL] [Abstract][Full Text] [Related]
4. Modulation of mouse RANKL gene expression by Runx2 and vitamin D3.
Kitazawa R; Mori K; Yamaguchi A; Kondo T; Kitazawa S
J Cell Biochem; 2008 Dec; 105(5):1289-97. PubMed ID: 18814144
[TBL] [Abstract][Full Text] [Related]
5. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter.
Drissi H; Pouliot A; Koolloos C; Stein JL; Lian JB; Stein GS; van Wijnen AJ
Exp Cell Res; 2002 Apr; 274(2):323-33. PubMed ID: 11900492
[TBL] [Abstract][Full Text] [Related]
6. Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells.
Liu J; Yang H; Liu W; Cao X; Feng X
J Cell Biochem; 2005 Nov; 96(4):716-27. PubMed ID: 16052479
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D and bone.
Suda T; Ueno Y; Fujii K; Shinki T
J Cell Biochem; 2003 Feb; 88(2):259-66. PubMed ID: 12520524
[TBL] [Abstract][Full Text] [Related]
8. TNF-alpha expression is transcriptionally regulated by RANK ligand.
Zou W; Amcheslavsky A; Takeshita S; Drissi H; Bar-Shavit Z
J Cell Physiol; 2005 Feb; 202(2):371-8. PubMed ID: 15389596
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the cytokine pattern of porcine bone marrow-derived cells treated with 1alpha,25(OH)D.
Sipos W; Duvigneau JC; Schmoll F; Exel B; Hofbauer G; Baravalle G; Hartl RT; Dobretsberger M; Pietschmann P
J Vet Med A Physiol Pathol Clin Med; 2005 Oct; 52(8):382-7. PubMed ID: 16176565
[TBL] [Abstract][Full Text] [Related]
10. Activated T lymphocytes support osteoclast formation in vitro.
Horwood NJ; Kartsogiannis V; Quinn JM; Romas E; Martin TJ; Gillespie MT
Biochem Biophys Res Commun; 1999 Nov; 265(1):144-50. PubMed ID: 10548505
[TBL] [Abstract][Full Text] [Related]
11. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity.
Lossdörfer S; Schwartz Z; Wang L; Lohmann CH; Turner JD; Wieland M; Cochran DL; Boyan BD
J Biomed Mater Res A; 2004 Sep; 70(3):361-9. PubMed ID: 15293309
[TBL] [Abstract][Full Text] [Related]
12. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
Koh JM; Lee YS; Byun CH; Chang EJ; Kim H; Kim YH; Kim HH; Kim GS
J Endocrinol; 2005 Jun; 185(3):401-13. PubMed ID: 15930166
[TBL] [Abstract][Full Text] [Related]
13. RANKL expression is related to the differentiation state of human osteoblasts.
Atkins GJ; Kostakis P; Pan B; Farrugia A; Gronthos S; Evdokiou A; Harrison K; Findlay DM; Zannettino AC
J Bone Miner Res; 2003 Jun; 18(6):1088-98. PubMed ID: 12817763
[TBL] [Abstract][Full Text] [Related]
14. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
[TBL] [Abstract][Full Text] [Related]
15. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
[TBL] [Abstract][Full Text] [Related]
16. Malignant B-lymphoid cells with bone lesions express receptor activator of nuclear factor-kappaB ligand and vascular endothelial growth factor to enhance osteoclastogenesis.
Shibata H; Abe M; Hiura K; Wilde J; Moriyama K; Sano T; Kitazoe K; Hashimoto T; Ozaki S; Wakatsuki S; Kido S; Inoue D; Matsumoto T
Clin Cancer Res; 2005 Sep; 11(17):6109-15. PubMed ID: 16144909
[TBL] [Abstract][Full Text] [Related]
17. Regulation of osteoclastogenesis by gap junction communication.
Matemba SF; Lie A; Ransjö M
J Cell Biochem; 2006 Oct; 99(2):528-37. PubMed ID: 16639710
[TBL] [Abstract][Full Text] [Related]
18. Novel vitamin D3 analogs, 1alpha, 25(OH)2D(3)-26, 23-lactam (DLAMs), antagonize bone resorption via suppressing RANKL expression in osteoblasts.
Inada M; Tsukamoto K; Hirata M; Takita M; Nagasawa K; Miyaura C
Biochem Biophys Res Commun; 2008 Aug; 372(3):434-9. PubMed ID: 18489902
[TBL] [Abstract][Full Text] [Related]
19. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
[TBL] [Abstract][Full Text] [Related]
20. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro].
Xiao XH; Zhou HD; Yuan LQ; Xie H; Liao EY
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2102-6. PubMed ID: 15730627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]